DrugPatentWatch Database Preview

Warner Chilcott Company Profile

« Back to Dashboard

What is the competitive landscape for WARNER CHILCOTT, and what generic alternatives to WARNER CHILCOTT drugs are available?

WARNER CHILCOTT has eighty-four approved drugs.

There are four US patents protecting WARNER CHILCOTT drugs.

There are eighty-eight patent family members on WARNER CHILCOTT drugs in forty-one countries and sixty-nine supplementary protection certificates in eleven countries.

Summary for Warner Chilcott

International Patents:	88
US Patents:	4
Tradenames:	42
Ingredients:	39
NDAs:	84
Patent Litigation for Warner Chilcott:	See patent lawsuits for Warner Chilcott
PTAB Cases with Warner Chilcott as patent owner:	See PTAB cases with Warner Chilcott as patent owner

Drugs and US Patents for Warner Chilcott

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Warner Chilcott	AMITRIL	amitriptyline hydrochloride	TABLET;ORAL	083939-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Warner Chilcott	PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; propranolol hydrochloride	TABLET;ORAL	071771-001	Jan 26, 1988		DISCN	No	No
Warner Chilcott	KANAMYCIN SULFATE	kanamycin sulfate	INJECTABLE;INJECTION	063092-001	Oct 11, 1989		DISCN	No	No
Warner Chilcott	DIAZEPAM	diazepam	INJECTABLE;INJECTION	071614-001	Oct 22, 1987		DISCN	No	No

Expired US Patents for Warner Chilcott

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Warner Chilcott	ACTONEL WITH CALCIUM (COPACKAGED)	calcium carbonate; risedronate sodium	TABLET, TABLET;ORAL	021823-001	Aug 12, 2005	6,465,443*PED
Warner Chilcott	ACTONEL WITH CALCIUM (COPACKAGED)	calcium carbonate; risedronate sodium	TABLET, TABLET;ORAL	021823-001	Aug 12, 2005	6,015,801*PED
Warner Chilcott	ACTONEL WITH CALCIUM (COPACKAGED)	calcium carbonate; risedronate sodium	TABLET, TABLET;ORAL	021823-001	Aug 12, 2005	6,096,342*PED
Warner Chilcott	ACTONEL WITH CALCIUM (COPACKAGED)	calcium carbonate; risedronate sodium	TABLET, TABLET;ORAL	021823-001	Aug 12, 2005	5,583,122*PED

Paragraph IV (Patent) Challenges for WARNER CHILCOTT drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Delayed-release Tablets	200 mg		2013-08-12
	Delayed-release Tablets	80 mg		2015-07-01
	Delayed-release Tablets	150 mg		2008-12-19
	Delayed-release Tablets	200 mg		2014-05-19
	Delayed-release Tablets	50 mg		2015-11-05

International Patents for Warner Chilcott Drugs

Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	0115703
Netherlands	300292
Germany	01201911
Bulgaria	66282

Supplementary Protection Certificates for Warner Chilcott Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1453521	39/2015	Austria		PRODUCT NAME: ETHINYLESTRADIOL UND EINE KOMBINATION VON LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 136021 20150224; FIRST REGISTRATION: SK 17/0017/15-S 20150211
1507558	2012/018	Ireland		PRODUCT NAME: ALISKIREN OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AMLODIPINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND HYDROCHLOROTHIAZIDE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF.; NAT REGISTRATION NO/DATE: EU/1/11/730/001-060 20111122; FIRST REGISTRATION NO/DATE: SWITZERLAND 6167801-6167805 20110705
1602370	2009/010	Ireland		PRODUCT NAME: ALISKIREN OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND HYDROCHLOROTHIAZIDE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF.; NAT REGISTRATION NO/DATE: EU/1/08/491/001-EU/1/08/491/080 20090116; FIRST REGISTRATION NO/DATE: 58935 01 58935 02 58935 03 58935 04 20081028
0503785	91330	Luxembourg		CERTIFICATE TITLE: UNE COMBINAISON D'OLMESARTAN MEDOXOMIL, OPTIONNELLEMENT SOUS LA FORME D'UN SEL PHARMACEUTIQUEMENT ACCEPTABLE ET D'HYDROCHLOROTHIAZIDE (OLMETEC PLUS)

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Warner Chilcott
• Warner Chilcott Llc